The Journal of Antimicrobial Chemotherapy is a journal of the British Society for Antimicrobial Chemotherapy (BSAC) and is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.

The Journal publishes original articles on lab-based and clinical use of antimicrobials including antibacterial, antiviral, antifungal, and antiprotozoal agents. We particularly welcome manuscripts on:

the practice of evidence-based medicine relating to antimicrobials (clinical trials, systematic reviews and meta-analyses)

antimicrobial treatment (pharmacokinetics, pharmacodynamics and prescribing practices)

the action of antimicrobial agents and the mechanisms, genetics and epidemiology of antimicrobial resistance

antimicrobial stewardship

the genetic basis of antimicrobial resistance.

We encourage our authors to:

offer evidence-based synthesis of knowledge and data useful for clinical practice

analyse, reflect and comment on the current state of the art and practice

consolidate our knowledge of antimicrobial agents and their use

consider the future of antimicrobial chemotherapy

In addition to the wealth of primary papers, the Journal also publishes review articles offering in-depth discussion on matters of topical concern. Lively leading articles offer incisive coverage of recent advances and controversies.

Other sections include:

For debate: International comment on contentious issues and ideas

Antimicrobial practice: Articles on practical prescribing and formulary issues

Correspondence: A section for scientists to present early observations of their work and to comment on published articles

The Journal publishes between two and eight supplements each year. These include Working Party reports of the British Society for Antimicrobial Chemotherapy, and original publications on pre-clinical and clinical aspects of drugs in development or the role of established drugs in specific therapeutic areas.